[
  {
    "ts": null,
    "headline": "U.S. mRNA Therapeutics CDMO Market to Hit Valuation of US$ 6.27 Billion by 2033 | Astute Analytica",
    "summary": "Shifting from its pandemic response origins, the market is diversifying into new vaccines and oncology. Asset-light biotechs fuel this growth, making specialized CDMOs essential partners for advancing next-generation mRNA therapies into the clinic and beyond.Chicago, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The US mRNA therapeutics CDMO market was valued at US$ 1.78 billion in 2024 and is expected to reach US$ 6.27 billion by 2033, growing at a CAGR of 15.01% during the forecast period 2025–2033. The o",
    "url": "https://finnhub.io/api/news?id=c588757df013ccd53132d9feda71055faa6484bc5c0213edd33ed2aa5dccacc9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755176400,
      "headline": "U.S. mRNA Therapeutics CDMO Market to Hit Valuation of US$ 6.27 Billion by 2033 | Astute Analytica",
      "id": 136349982,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Shifting from its pandemic response origins, the market is diversifying into new vaccines and oncology. Asset-light biotechs fuel this growth, making specialized CDMOs essential partners for advancing next-generation mRNA therapies into the clinic and beyond.Chicago, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The US mRNA therapeutics CDMO market was valued at US$ 1.78 billion in 2024 and is expected to reach US$ 6.27 billion by 2033, growing at a CAGR of 15.01% during the forecast period 2025–2033. The o",
      "url": "https://finnhub.io/api/news?id=c588757df013ccd53132d9feda71055faa6484bc5c0213edd33ed2aa5dccacc9"
    }
  }
]